The Analgesic Effects of Supraspinal μ and δ Opioid Receptor Agonists Are Potentiated during Persistent Inflammation

@article{Hurley2000TheAE,
  title={The Analgesic Effects of Supraspinal $\mu$ and $\delta$ Opioid Receptor Agonists Are Potentiated during Persistent Inflammation},
  author={R. Hurley and Donna L. Hammond},
  journal={The Journal of Neuroscience},
  year={2000},
  volume={20},
  pages={1249 - 1259}
}
This study examined the antihyperalgesic and antinociceptive effects of opioid receptor agonists microinjected in the rostral ventromedial medulla (RVM) of rats 4 hr, 4 d, and 2 weeks after the induction of an inflammatory injury by injection of complete Freund's adjuvant (CFA) in one hindpaw. Nociceptive sensitivity of the ipsilateral, inflamed and the contralateral, uninflamed hindpaws was determined by the radiant-heat paw withdrawal test. The antihyperalgesic potency of the μ opioid… 
View on SFN
jneurosci.org
197 Citations
Highly Influential Citations
6
Background Citations
82
Methods Citations
15
Results Citations
9

Figures and Tables from this paper

197 Citations

Contribution of Endogenous Enkephalins to the Enhanced Analgesic Effects of Supraspinal μ Opioid Receptor Agonists after Inflammatory Injury

It is suggested that persistent inflammatory injury increased the release in the RVM of opioid peptides with preferential affinity for the δ opioid receptor, which can interact in a synergistic or additive manner with an exogenously administered μ opioid receptor agonist.

Persistent inflammatory pain decreases the antinociceptive effects of the mu opioid receptor agonist DAMGO in the locus coeruleus of male rats

Inflammation-induced changes in rostral ventromedial medulla mu and kappa opioid receptor mediated antinociception

Delta-Opioid Receptor Analgesia Is Independent of Microglial Activation in a Rat Model of Neuropathic Pain

DOR analgesia is different from analgesia induced by MOR and KOR receptors because it does not dependent on injury-induced microglial activation, and DOR agonists appear to be the best candidates for new drugs to treat neuropathic pain.

Differential noxious and motor tolerance of chronic delta opioid receptor agonists in rodents

Mechanisms Responsible for the Enhanced Antinociceptive Effects of μ-Opioid Receptor Agonists in the Rostral Ventromedial Medulla of Male Rats with Persistent Inflammatory Pain

Microinjection of fixed dose combinations of DAMGO and DELT in the RVM of naive rats indicated that these agonists interact synergistically to produce antinociception when DAMGO is present in equal or greater amounts than DELT and, additively, when DELT is the predominant component.

Spinal administration of a δ opioid receptor agonist attenuates hyperalgesia and allodynia in a rat model of neuropathic pain

The role of μ-opioid receptors in inflammatory hyperalgesia and α2-adrenoceptor-mediated antihyperalgesia

Involvement of opioid receptors in electroacupuncture-produced anti-hyperalgesia in rats with peripheral inflammation

Spinal and Peripheral Mechanisms Involved in the Enhancement of Morphine Analgesia in Acutely Inflamed Mice

It is described here that lower doses of systemic morphine are necessary to increase thermal withdrawal latencies measured in both hind paws of mice acutely inflamed with carrageenan than in healthy ones, and enhanced responsiveness to the peripheral analgesic effect of NO may be also underlying the bilateral potentiation of morphine-induced analgesia in acutely inflated mice.
...

References

SHOWING 1-10 OF 58 REFERENCES

Enhanced descending modulation of nociception in rats with persistent hindpaw inflammation.

After the thoracic lidocaine block, rats showed increases in background activity, expansion of the receptive fields, and increased responses to noxious thermal, mechanical, and electrical stimuli, suggesting the enhancement of hyperalgesia in DLFX rats.

Contribution of supraspinal mu- and delta-opioid receptors to antinociception in the rat.

Evidence is provided to support the suggestion that both supraspinal mu- and delta-opioid receptors contribute to the production of antinociception, in the rat.

Antinociceptive effects of μ- and κ-agonists in inflammation are enhanced by a peripheral opioid receptor-specific mechanism

Suppression of nociceptive responses by spinal mu opioid agonists: effects of stimulus intensity and agonist efficacy.

The present studies confirm the pharmacodynamically based prediction that for a given change in stimulus intensity, anesthetics with a high efficacy (DAG and SUF) show less shift in their dose response curves with a given increase in stimulusintensity than an agonist with low efficacy (MOR).

Medullary μ and δ opioid receptors modulate mesencephalic morphine analgesia in rats

Descending modulation of opioid-containing nociceptive neurons in rats with peripheral inflammation and hyperalgesia

Interaction Between Medullary and Spinal δ1 and δ2 Opioid Receptors in the Production of Antinociception in the Rat

The results suggest that delta2 opioid receptor agonists capable of crossing the blood-brain barrier will be more potent or efficacious analgesics than delta1 opioid receptors agonists after systemic administration.

Antinociceptive interactions of opioid delta receptor agonists with morphine in mice: supra- and sub-additivity.

Opiates suppress carrageenan-induced edema and hyperthermia at doses that inhibit hyperalgesia

Alteration of Descending Modulation of Nociception during the Course of Monoarthritis in the Rat

A discrepancy between the behavioral and electrophysiological findings suggests that inputs activated during chronic monoarthritis may fail to recruit DNIC and may thus be functionally different from those activated in the acute stage of inflammation.
...